Artificial Intelligence in Drug Discovery

Using artificial intelligence for drug discovery is the practice of using computational methods to research new pharmaceuticals, and repurpose existing compounds for new use cases.

Computational Drug Discovery Using AI

Artificial intelligence (AI), and more accurately Machine Learning (ML), is accelerating drug discovery and development timelines, and simultaneously reducing costs associated with pharmaceutical research.

BioSymetrics uses a patent pending Contingent-AI™ platform, that trains machine learning models to reduce bias by making decisions “contingent” on early stage data collection and feature engineering variables. The result provides a higher level of confidence in the output of the model, leading to greater precision.

How Contingent-AI™ Works

Artificial Intelligence (AI) or Machine Learning (ML) models are commonly run against “feature sets”.  The data scientists’ decision on how to create feature sets can dramatically affect the outcome of the machine learning by unintentionally inferring bias.  Contingent-AI™ seeks to train and run machine learning models against various permutations of feature sets in an effort to reduce bias and de-noise the machine learning output.

Contingent-AI Example

For example, imaging data can vary greatly by the contrast settings set by the technician when an MRI was captured.  Contingent-AI will evaluate different variations of the imaging feature set with image contrast at different settings, reporting back if results are “contingent” on a decision made in early stages of data collection or feature engineering.  BioSymetrics output reports will showcase the contingency of a machine learning model’s results based on variances in the feature engineering stage and data de-bias stages.

Who Uses Contingent Artificial Intelligence (Contingent-AI™)?

Artificial Intelligence for Drug Discovery Roles and Practitioners:

  • Bioinformatics Experts
  • Data Scientists
  • Chemists and Chemical Scientists
  • Contract Research Organizations (CRO’s)
  • Pharmaceutical Researchers

Use Cases for Medical Machine Learning / BioMedical Artificial Intelligence

Read our artificial intelligence drug discovery Product Descriptions

Other Applications of BioMedical Artificial Intelligence / Contingent-AI

  • Precision Medicine
  • Value Based Care
  • Medical / Clinical Research

BioSymetrics Partnerships:

AI Drug Discovery References:

Contingent-AI™

Accelerate Discovery

Discovery starts with a discussion about your project and requirements.